These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17240107)

  • 41. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.
    Tubau F; Liñares J; Rodríguez MD; Cercenado E; Aldea MJ; González-Romo F; Torroba L; Berdonces P; Plazas J; Aguilar L; Delgado A; García-Escribano N;
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):308-13. PubMed ID: 20022193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of oral cephalosporin BAY v 3522 compared with other oral cephalosporins.
    Locher R; Strässle A; Kayser FH
    Drugs Exp Clin Res; 1990; 16(10):515-25. PubMed ID: 2100734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
    Dubreuil L; Derriennic M; Sedallian A
    Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative sensitivity of 207 strains of strict anaerobic bacteria to piperacillin and 4 other antibiotics].
    Reynaud A; Drugeon HB; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 Nov; 33(9):891-5. PubMed ID: 3909081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3959-62. PubMed ID: 16982780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activities of faropenem against 579 strains of anaerobic bacteria.
    Wexler HM; Molitoris D; St John S; Vu A; Read EK; Finegold SM
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3669-75. PubMed ID: 12384389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
    Phillips OA; Rotimi VO; Jamal WY; Shahin M; Verghese TL
    J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of action and antimicrobial activity of ceftobiprole.
    Morosini MI; Díez-Aguilar M; Cantón R
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 3(Suppl 3):3-10. PubMed ID: 31364335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
    Hamilton-Miller JM; Shah S
    Int J Antimicrob Agents; 1998 Nov; 10(4):321-4. PubMed ID: 9916909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of gemifloxacin (SB 265805) against anaerobes.
    Goldstein EJ; Citron DM; Warren Y; Tyrrell K; Merriam CV
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2231-5. PubMed ID: 10471570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2599-604. PubMed ID: 7872754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.
    Citron DM; Tyrrell KL; Merriam CV; Goldstein EJ
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1627-32. PubMed ID: 20100877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The in vitro activity of trospectomycin against anaerobic bacteria.
    Chisari G; Lo Bue AM; Nicoletti G
    J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3507-13. PubMed ID: 16940056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Retrospective Analysis of Anaerobic Bacteria Isolated in 236 Cases of Pleural Empyema and their Prevalance of Antimicrobial Resistance in Turkey.
    Demirci M; Gemicioglu B; Saribas S; Taner Z; Mamal-Torun M; Karatoka B; Asik-Cagli L; Guven O; Demiryas S; Kocazeybek BS; Bahar-Tokman H
    Clin Lab; 2018 Jul; 64(7):1269-1277. PubMed ID: 30146848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.